4-[5-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]-3-methyl-1-(2-methylpropyl)pyrazole
C20H28BFN2O3 — CID 156891354
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[5-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]-3-methyl-1-(2-methylpropyl)pyrazole
4-[5-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]-3-methyl-1-(2-methylpropyl)pyrazole (PubChem CID 156891354) has the molecular formula C20H28BFN2O3 and a molecular weight of 374.27 g/mol. Its IUPAC name is 4-[5-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]-3-methyl-1-(2-methylpropyl)pyrazole.
Molecular Properties
| Compound Name | 4-[5-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]-3-methyl-1-(2-methylpropyl)pyrazole |
|---|---|
| PubChem CID | 156891354 |
| Molecular Formula | C20H28BFN2O3 |
| Molecular Weight | 374.27 g/mol |
| Exact Mass | 374.22 |
| IUPAC Name | 4-[5-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]-3-methyl-1-(2-methylpropyl)pyrazole |
| SMILES | Cc1nn(CC(C)C)cc1Oc1cc(F)ccc1B1OC(C)(C)C(C)(C)O1 |
| InChI | InChI=1S/C20H28BFN2O3/c1-13(2)11-24-12-18(14(3)23-24)25-17-10-15(22)8-9-16(17)21-26-19(4,5)20(6,7)27-21/h8-10,12-13H,11H2,1-7H3 |
| InChIKey | HESACHBIYDBAOB-UHFFFAOYSA-N |
| XLogP | 4.08 |
| TPSA | 45.51 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 374.27 |
| LogP ≤ 5 | 4.08 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156891354 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.